When you need an answer about substance use, whether for personal accountability or family safety, the last thing you want is more unce...
In a standard clinical setting, specimen rejection rates hover between 0.2% and 1.3%. But in high-stakes environments like emergency ro...
Initial drug screens for amphetamines can produce false positives in up to 35% of cases, often triggered by common over-the-counter dec...
Clinical data suggests up to 50% of chronic pain patients may have at least one "unexpected" urine drug test result during their treatm...
For clinical directors and operations managers, administrative burdens are the primary constraint in high-volume drug testing environme...
Medication-Assisted Treatment (MAT) is a cornerstone of modern opioid use disorder (OUD) management. The data is clear: methadone can r...
Effective drug testing in a recovery setting is a delicate balance. You need a program that promotes accountability and ensures residen...
If you are managing a drug testing program in 2026, you already know that the "one-size-fits-all" corporate policy is completely obsole...
If you are evaluating workplace drug testing solutions in 2026, the landscape looks drastically different than it did just two y...
If you are managing a workplace testing program, running a clinical facility, or overseeing compliance, you already know that simply fi...
If you are evaluating your workplace drug testing policies in 2026, you are likely feeling a very specific type of administrative whipl...
If you are currently evaluating your organization's drug testing policy in 2026, you are likely wrestling with a fundamental shift in w...
